This analysis reveals challenges in corporate practices and data quality for sustainable disclosure in China, suggesting pathways for integration with international standards.
As international sustainable disclosure standards accelerate their integration, the convergence of global sustainable disclosure frameworks is strengthening. However, regional differences and gaps in corporate practices remain significant. This paper examines the evolution and focus of existing international sustainable disclosure standards, China's localization efforts, and corporate practices from three dimensions. It analyzes the core requirements of international mainstream standards and academic disputes regarding the feasibility of disclosure and data quality, revealing theoretical breakthroughs and practical challenges in China's research on mandatory disclosure, report verification, and other fields. On this basis, the case study of Myriad Medical is used to analyze the innovative path of Chinese enterprises in sustainable development. The study indicates the design and application of sustainable disclosure guidelines is of significance for entering global capital markets and promoting development concepts such as carbon peaking and carbon neutrality. On the corporate side, companies should enhance strategic resilience by prioritizing the identification of key issues, establishing a tiered data management mechanism, gradually improving disclosure capabilities, and flexibly designing disclosure schemes. Meanwhile, sustainable development disclosure requires strengthened institutional safeguards to promote the integration of China's sustainable development practices with the international governance system, providing replicable transformation models for emerging market countries.
No takes yet. Share an insight, caveat, or question.
Pang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: